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Summary Various doses (1 ug to 10mg) of oestriol (E3) were intraperitoneally injected into mice immediately
after subcutaneous inoculation of an oestrogen receptor-negative lymphoma cell line (KE-5) established from
a spontaneously developed AKR thymic lymphoma. The growth of KE-5 cells was markedly promoted by E3
at the early stage of tumour growth. At this stage, 1 Mg E3 enhanced tumour growth significantly and the
maximum effect was obtained with 1 mg E3. Normal female mice showed a higher incidence and shorter
latency than males. However, once tumours became palpable, the tumour growth rate appeared to be
unaffected. Histological observations using Alcian blue and colloidal iron revealed a marked increase of
hyaluronic acid in the subcutaneous connective tissue of the tumour-injection site within 3-5 days after
intraperitoneal administration of 1 mg E3. Biochemical analyses showed a rapid and marked increase in skin
hyaluronic acid content to over 3 times the control levels (0.25+0.10mg g-1 skin) within 3 days of E3
administration. Subcutaneous inoculation of KE-5 cells together with hyaluronic acid (0.2mg) resulted in
markedly enhanced tumour growth, particularly at the early stage. These results suggest that an increase in
stromal hyaluronic acid content is the most likely mechanism responsible for the promoting effect of E3 on
KE-5 cells.
Oestrogens may be carcinogenic and promote tumour
growth in several cancers (Noble, 1964). The most common
explanations have centred on oestrogen receptor-mediated
cytological changes in target tumour cells. For example,
oestrogens stimulate tumour cells to synthesise specific 'pro-
teins (Rochefort et al., 1986) and to increase nuclear RNA
polymerase activity (Clark & Peck, 1979). Rochefort et al.
(1986) have further suggested that autocrine growth factors
can be encoded by oncogenes and expressed at a higher level
in transformed cells. The participation of oestrogen-induced
hormones including prolactin (Noble et al., 1980) and pro-
gesterone (Clark & Peck, 1979) has also been reported.
It is also conceivable that oestrogens promote tumour
growth indirectly by modulating the in situ tumour environ-
ment rather than directly stimulating tumour cells to proli-
ferate via oestrogen receptors. Changes in various cellular
components of the tumour environment may be involved in
enhancement of tumour growth. Oestrogens enhance the
phagocytic activity of macrophages (Nicol et al., 1964; Sljivic
& Warr, 1973). Although host macrophages have been
reported to be tumoricidal (Evans, 1973; Levy & Wheelock,
1974), possible involvement of macrophages in enhancing the
progression of certain tumours has also been demonstrated
(Gorelik et al., 1982; Mukai et al., 1987). Oestrogens also
stimulate mast cells (Asboe-Hansen, 1963): tumour-
enhancing activity of mast cells has been reported (Roche,
1985), although these cells have also been characterized as
antitumour effector cells (Farram et al., 1980; Henderson et
al., 1981). Eosinophils contain oestrogen receptors
(Tchernitchin & Tchernitchin, 1976), and anti-tumour
activity of eosinophils (Jong & Klebanoff, 1980; Iwasaki et
al., 1986) has been demonstrated. Moreover, oestrogens have
been reported to inhibit natural killer cell activity (Seaman et
al., 1978), and cell-mediated immunity (Waltman et al., 1971;
Luster et al., 1980).
On the other hand, changes in the non-cellular compo-
nents of the tumour environment may also be related to
enhancement of tumour growth. Oestrogens induce an
increase in the tissue contents of water and acid glycosami-
noglycans, particularly hyaluronic acid in skin (Asboe-
Hansen, 1963; Sobel et al., 1965; Bentley et al., 1986).
Furthermore, the promoting effect of hyaluronic acid on
tumour growth has been reported by many investigators,
such as Takeuchi (1966) in Ehrlich ascites tumour cells and
by Toole et al. (1979) in rabbit V2 carcinoma.
In the present study, we found for the first time that the
growth of an established thymic lymphoma having no oes-
trogen receptors was dramatically promoted by E3. In order
to clarify the possible mechanism of the promoting effect of
E3 on receptor-negative tumours, changes in the in situ
tumour environment were studied in cellular and non-cellular
components of subcutaneous connective tissue into which
tumour cells were inoculated.
Materials and methods
Animals
Inbred AKR/Ms mice were originally obtained from Saitama
Prefectural Cancer Centre (Saitama, Japan) and have been
maintained in our laboratory by sib-mating for about 4
years. All were housed in a climate-controlled room and
were fed standard laboratory chows and water ad libitum.
Unless otherwise stated, male mice aged between 2 and 4
months were used for this study in order to obviate or
minimise any undesirable disturbance by endogenous
oestrogens.
Establishment of a thymic lymphoma cell line (KE-5)
Small pieces of a freshly excised lymphoma that had sponta-
neously developed in the thymus of a 7-month-old female
AKR/Ms mouse were incubated and agitated in Hank's
medium containing 0.7mgml-1 collagenase (WAKO Pure
Chemical Industries Ltd, Osaka, Japan) at 37°C for 30min.
The digested cell suspension was filtered through a stainless
steel mesh and washed with PBS. The cells were maintained
in RPMI-1640 culture medium (Nissui Pharm. Co. Ltd,
Tokyo, Japan), supplemented with 10% heat-inactivated
fetal calf serum (FCS), penicillin (100Uml-1), streptomycin
(0.1 mgml -1), 5 x l0- M 2-mercaptoethanol (2ME),
2 x 10- M L-glutamine and x 10-3 M sodium pyruvate at
37°C in an atmosphere of 5% CO2 in air. During the
maintenance of these original thymic lymphoma cells, several
sublines were cloned by limiting dilution (0.25 cells per well).
One of the sublines (KE-5) was characterised by stable and
relatively slow growth in vivo, and' this line was used
throughout the present study. By indirect immunofluores-
cence using rat monoclonal antibodies (Sera Lab. Ltd,
Sussex, England) against mouse T lymphocyte antigens, KE-
5 cells were characterised as: Thy-1, highly positive; Lyt-l
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and Lyt-2, clearly negative. However, we were unable to
detect any L3T4 antigen under our present assay conditions.
Oestrogen receptor assay
The biochemical quantitative assay of oestrogen receptor was
carried out using tritiated oestradiol, E2 ([2,4,6,7-3H]-E2;
New England Nuclear, Boston, USA) and tritiated oestriol,
E3 ([2,4,6,7-3H]-E3; New England Nuclear) according to the
method of Nishimura et al. (1982). As a positive control, a
homogenate of uteri from 10 AKR mice was used in each E2
and E3 receptor assay. The amounts of oestrogen receptors
in uterus and KE-5 cells were calculated by Scatchard
analysis.
Tumour growth
Cultured KE-5 cells were washed twice in PBS and the cell
suspension (105 cells in 0.2ml PBS) subcutaneously injected
into the shaved right flank of mice at the level of the twelfth
rib. Various doses (1 ig to 1Omg) of E3 in 1.Oml of aqueous
suspension (Estriel, Mochida Pharm. Co., Tokyo, Japan)
were injected intraperitoneally into at least 10 mice in each
group immediately after the KE-5 cell inoculation. The
control mice were given 1.0ml of solvent (Mochida; 50mg
arabic gum and 1 mg polysolvent 80 in 100ml isotonic
saline) without E3 in the same manner. The day when
tumours became palpable was designated as the day of onset
of the tumour. The size of each tumour was thereafter
measured daily with callipers until the day of death of each
animal and expressed as the mean diameter in millimetres.
Histological observations
KE-5 cells (105 cells in 0.2ml PBS) were subcutaneously
injected into the right flank of male mice, and this was
followed by intraperitoneal administration of lmg E3
(1mgml-l solvent) or solvent alone. As non-tumour cell
controls for KE-5 cells, normal thymoocytes (105 cells in
0.2ml PBS) from the thymus of 4-week-old mice were
injected subcutaneously in the same manner. Controls with-
out cells were also prepared by injection of an equal volume
of PBS in the same way as above. Each group consisted of
specimens obtained from at least five mice. A papule about
7mm in diameter usually formed at the injection site for a
short time. Three to five days after the injection, the skin at
the injection site was excised.
For studies on cellular components, the excised skin
specimens were frozen and sectioned at a thickness of 6 um.
Macrophages were stained according to the method of Leder
(1967) for non-specific esterase, and that of Barka &
Anderson (1962) for acid phosphatase. Eosinophils were
stained by the method of Graham & Karnovsky (1966) for
peroxidase. Mast cells were also stained with toluidine blue
for glycosaminoglycans (Culling et al., 1985). The number of
these cells located in the subcutaneous loose connective
tissue under the panniculus carnosus into which KE-5 cells
were usually inoculated was counted (cells per unit area;
5.76 x 10-8m2) using an optical square micrometer.
For studies on non-cellular components, the excised skin
specimens were fixed in Carnoy's solution, embedded in
paraffin and sectioned at a thickness of 6gum. The sections
were stained with Alcian blue at pH 2.5 and pH 1.0
according to the method of Lev & Spicer (1964) for acid
glycosaminoglycans and also with colloidal iron according to
the method of Mowry (1958). In addition, collagen fibres
were stained by van Gieson's method (Berry, 1898).
Hyaluronic acid assay
The content of hyaluronic acid in skin was measured in 10
mice each that had received 1 mg E3 or solvent only
intraperitoneally. The skins were excised, defatted and
homogenised in 0.1 M Tris-HCl buffer (pH 7.5). The samples
were then heated for 10min in boiling water to denature
enzymes in the skin. The skin homogenates were digested
with 1 mg of pronase (protease, type XIV, Sigma, St Louis,
USA) per ml of each sample at 37°C for 24h. The digestion
was repeated once more under the same conditions. The
digested samples were then placed in boiling water for
Omin to destroy the enzyme activity, and dialysed against
distilled water, which was changed at least two times.
Residues were removed by centrifugation at 80000g for 1 h
at 4°C. Aliquots (100 pl) of the supernatants were then
digested with 0.01 U of streptococcal hyaluronidase (Hyalur-
onidase SD, Seikagaku Kogyo Co. Ltd, Tokyo) in 20,ul
of 0.1 M phosphate buffer (pH 6.2) for 00min at 37°C. The
amounts of terminal N-acetylglucosamine residues produced
by the enzymatic digestion of hyaluronic acid were measured
by the method of Reissig et al. (1955). The content of
hyaluronic acid was determined from the values of a
standard curve obtained by digesting various amounts of
hyaluronic acid (human umbilical cord, grade I, Sigma) with
the enzyme and expressed as weight per gram wet skin
weight.
Tumour growth with hyaluronic acid
KE-5 cells (105 cells) suspended in 0.2ml PBS containing
0.2mg hyaluronic acid were injected subcutaneously into 14
mice as described above. The same number of control mice
received KE-5 cells only without hyaluronic acid. The day
when a tumour became palpable was designated as its day of
onset and the size of the tumour was thereafter measured
daily with callipers until the death of each animal, being
expressed as the mean diameter in mm.
Statistical analysis
Statistical significance of differences in mean values was
assessed using Student's t test; a P value less than 0.05 was
considered significant.
Results
Oestrogen receptor concentration in KE-5 lymphoma cells
Biochemical analyses revealed an undetectable amount of E3
receptor of less than lOfmolml-1 protein, which was the
lowest value measurable in the assay of the cytosol and
nuclear fractions from KE-5 cells, whereas a substantial
amount of E3 receptor was detected in uterine tissue
(40.6fmolmg-' protein in cytosol and 26.2fmolmg-1 pro-
tein in the nuclear fraction) under the same assay conditions
as shown in Figure 1. Although the affinity of E2 for
oestrogen receptor is known to be about ten times higher
than that of E3 (Martucci & Fishman, 1976), E2 receptor
was also undetectable in KE-5 cells, in contrast to much
higher amounts of E2 receptor in uterine tissue
(431.4fmolmg-1 protein in cytosol and 234.8fmolmg-1
protein in the nuclear fraction) than those of E3 receptor.
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Figure 1 Quantification of oestrogen receptor in uterus and
KE-5 cells. Specific binding of 3H-oestrogens (E) by cytosol
fractions or nuclear extracts (y axis) was plotted against the
concentration of bound free 3H-E (x axis). (E2 receptor, uterus:
0, KE-5 cells: *; E3 receptor, uterus: A, KE-5 cells: A.)
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Effect of E3 on KE-5 lymphoma cell growth
Various doses (1 jug to 1Omg) of E3 were intraperitoneally
injected into mice immediately after subcutaneous inocula-
tion of KE-5 cells (105 cells in 0.2ml). The incidence and
onset of tumours in mice are shown in Figure 2a. All groups
of animals that received E3 showed earlier onset and higher
incidence of tumour in comparison with the group of
controls that received solvent only without E3. A dose of
1 ,ug E3 enhanced tumour growth significantly. Tumours in
mice that received 1 mg E3 grew more rapidly and more
frequently than those in mice that received 1-100jig E3 and
showed a 100% incidence by 20 days after the tumour
inoculation, whereas the maximum incidence in control mice
was only about 60%. There was no difference in tumour
incidence and onset between doses of 1 mg and 10mg.
Although markedly higher incidence and earlier onset of
tumours in the early stage of tumour growth were observed
in mice treated with E3 than in solvent-administered
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Figure 2 (a) Effect of various doses of E3 on the incidence and
onset of tumours in male mice. Either E3 (1 g: A, 10 ig: *,
100 jug: *, 1 mg: 0, 10mg: *) or solvent (0) was administered
immediately after inoculation of KE-5 cells. (b) Effect of 1mg E3
on the growth rate of tumours after onset (solvent, 0; E3, *).
Bars represent standard deviations. P value for each time point is
greater than 0.05. (c) Effect of 1 mg E3 on the incidence and onset
of tumours in male and female mice. (Male, solvent: 0, E3: 0;
Female, solvent: A, E3: A.)
controls, the growth rate after tumours had become palpable
was not different between the two groups of mice treated
with 1 mg E3 and solvent only (Figure 2b).
The effect of 1 mg E3 on the growth of KE-5 cells was
compared between male and female mice (Figure 2c).
Control female mice showed a higher incidence and earlier
onset of tumours than control males. However, 1 mg E3
raised the incidence of tumours in males to almost 90% of
that in females. The latent period before onset of tumours
was shortened by E3 administration in both sexes.
Histological changes in tumour environment after E3
administration
The changes in cellular components in the subcutaneous
loose connective tissue at the sites of injection of PBS alone,
normal thymocytes and KE-5 cells for both the E3- and
solvent-administered control groups after 5 days are shown
in Table I. No changes were found in the number and
distribution of macrophages and mast cells in all groups,
regardless of E3 administration. Furthermore, the staining
intensity of both enzymatic activities of macrophages and
glycosaminoglycans of mast cells also showed no change. In
contrast, eosinophils increased significantly in both solvent-
administered groups for normal thymocyte (P<0.01) and
KE-5 cell (P<0.02) inoculation in comparison with those in
the other solvent group for PBS injection, indicating an
increase in eosinophils after injection of thymocytes or KE-5
cells only in the absence of E3. The number of eosinophils in
the site of subcutaneous injection of PBS only in mice that
had received intraperitoneal solvent only was not signifi-
cantly different (P>.0.05) from that in the subcutaneous
connective tissue of non-treated normal controls. Comparing
each of the groups, E3 caused a marked decrease in the
number of eosinophils in the groups administered PBS
(P<0.01), thymocytes (P<0.001) and KE-5 cells (P<0.001).
Fibroblasts showed little apparent morphological change
after E3 administration, as observed by the staining methods
employed in this study.
As for changes in non-cellular components, acid glycos-
aminoglycan was stained with Alcian blue and colloidal
iron. The subcutaneous loose connective tissue in all groups
of mice that had received 1 mg E3 3-5 days previously was
much more deeply stained with Alcian blue at pH 2.5 than
that of the normal and solvent-administered control groups,
as shown in Figure 3a and b. Colloidal iron staining also
showed similar patterns of increased acid glycosaminoglycan.
Such an increase in the staining intensity of this matrix was
no longer detected when the samples were stained with
Alcian blue at pH 1.0, indicating that the increased acid
glycosaminoglycan in the subcutaneous loose connective
tissue was hyaluronic acid having no sulphuryl, rather than
chondroitin sulphate (Lev & Spicer, 1964). In addition, by
van Gieson staining, a more loose and irregular arrangement
of collagen fibres in the subcutaneous connective tissue of
mice treated with E3 than that of non-treated mice was
observed, as shown in Figure 4a and b.
Effect of E3 on the hyaluronic acid content of the skin
The hyaluronic acid content per g of wet skin after intraperi-
toneal injection with and without 1 mg E3 is shown in Figure
5. Compared with the amount in normal controls
(0.25+0.10mgg-I skin), the hyaluronic acid content
increased rapidly by 2.8-fold (0.70 +0.17mgg1 skin) as early
as 1 day after E3 administration. The hyaluronic acid
content reached its peak (0.89+0.17mgg-i skin) on day 3.
Thereafter, it decreased gradually and returned to the
normal level by day 14. On the other hand, solvent did not
cause any increase in hyaluronic acid.
Effect of hyaluronic acid on KE-5 lymphoma cell growth
KE-5 cells (105) in 0.2ml PBS containing 0.2mg hyaluronic
acid were subcutaneously injected and the tumour growth566 R. KAWATSU et al.
Table I Changes in the number of macrophages, mast cells and eosinophils in the subcutaneous connective tissues
Inoculation groups?
Cellular PBS Thymocytes KE-5 cells
components Normal
tested control Solvent E3 Solvent E3 Solvent E3
Macrophages
ib 47+13d 56+15 52+9 45+9 45+4 44+12 46+9
IIC 39+23 38+11 36+8 33+9 30+3 42+13 27+4
Mast cells 0.9+0.9 0.5+0.5 0.4+0.9 1.0+0.7 0.5+0.3 1.0+0.7 0.3+0.3
Eosinophils 7+6 12+7 4+3 22+5 3+1 20+5 2+1
aDetails are described in the text. Data were obtained 5 days after the inoculations.
bAcid phosphatase-positive cells.
cNon-specific esterase-positive cells.
dMean +standard deviation (s.d.) in 5.76 x 10-8m2.
Figure 3 The subcutaneous loose connective tissue under panni- Figure 4 The subcutaneous loose connective tissue under the
culus carnosus (P) stained with Alcian blue at pH 2.5, 3 days panniculus carnosus (P) stained by van Gieson's method, 5 days
after intraperitoneal administration of solvent (a) or 1 mg E3 (b). after intraperitoneal administration of solvent (a) or 1 mg E3 (b).
The connective tissue is much more deeply stained in (b) than in The collagen fibres are more loosely arranged in (b) than in (a).
(a). x 800. x 800.
was observed (Figure 6). The mice that received KE-5 cells
together with hyaluronic acid showed a higher incidence and
earlier onset of tumours than controls that received KE-5
cells only. The former showed an incidence as high as 92.9%
by 20 days after the inoculation of KE-5 cells together with
hyaluronic acid. On the other hand, the maximum incidence
of tumours in control mice given KE-5 cells only without
hyaluronic acid was less than 50%.
Discussion
Although E3 is believed to be absent in rodents (Turner &
Bagnara, 1976) and has a much weaker effect on the
reproductive organs than other compounds (Clark et al.,
1977), E3 has been employed as a unique steroid that has a
broad action on various other cells and tissues of rodents
(Thompson et al., 1965; Kotani et al., 1979; Fujii et al.,
1985). The present study demonstrated that the growth of
receptor-negative KE-5 lymphoma cells was markedly pro-
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Figure 5 The content of hyaluronic acid in skin after intraperi-
toneal administration of solvent (0) or lmg E3 (0) to each of
10 mice. Bars represent standard deviations.
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Figure 6 The effect of hyaluronic acid on the incidence and
onset of tumours in male mice. KE-5 cells (105 cells) were
suspended in either PBS only (0) or PBS containing 1 mgml-'
hyaluronic acid (0), and injected into the skin in a total volume
of 0.2ml.
moted by E3 at the early stage of tumour growth. A small
dose of 1 jug E3 enhanced tumour growth significantly and
1 mg E3 produced the maximum effect. Furthermore, it was
suggested that endogenous oestrogen would be effective for
tumour growth, since normal females showed higher inci-
dence and shorter latency than normal males. However, it
should be noted that after onset the growth rate of tumours
appeared to be unaffected by E3, possibly indicating that the
latent period before onset is critical in this tumour model.
The latent period may reflect tumour cell survival rather
than cell proliferation. If so, then the tumour-promoting
effect of E3 may be interpreted simply as an E3-induced
improvement in the 'take' rate of KE-5 cells.
Histological observations on non-cellular components of
the tumour environment revealed a rapid increase of hyalur-
onic acid in the subcutaneous connective tissue within 3-5
days after E3 administration. In parallel with the histological
observations, a more than three-fold increase in the hyaluro-
nic acid content of the skin 3 days after E3 administration
was detected by biochemical assay. These results suggest a
possible role of hyaluronic acid in tumour promotion at the
early stage of tumour growth. This possibility was supported
by observations of tumour growth after inoculation of KE-5
cells together with hyaluronic acid. The growth of KE-5 cells
was improved by simultaneous injection of hyaluronic acid,
and a great difference in incidence and latent period was also
seen in the early developmental stage. However, the mecha-
nisms of tumour promotion by hyaluronic acid are unclear
at present. Rogers (1961) has suggested that hyaluronic acid
is involved in the control of water retention, rate of diffu-
sion, lubrication, macroionic function and so on. Takeuchi
(1966) has proposed that hyaluronic acid protects the surface
of tumour cells and promotes exchange of tumour metabo-
lites. A higher concentration of acid glycosaminoglycans in
various neoplastic tissues in comparison with non-neoplastic
tissues has been reported by many investigators (Fukatsu et
al., 1988).
According to Bentley et al. (1986), the effects of oestrogen
on an increase in hyaluronic acid in skin are probably
mediated through oestrogen receptors in dermal fibroblasts.
The dermal fibroblasts also have testosterone receptors
(Jung-Testas et al., 1976). Furthermore, it is known that
testosterone increases the amount of metachromatic ground
substance, particularly hyaluronic acid in skin (Branwood,
1963). Therefore, like oestrogens, testosterone may also have
potent tumour-promoting activity. In contrast, adrenal corti-
cal steroids inhibit the synthesis and metabolism of acid
glycosaminoglycans in skin (Branwood, 1963; Asboe-Hausen,
1963). However, the effect of progesterone on hyaluronic
acid production is still not established.
As another histological change in non-cellular compo-
nents, we observed rearrangement of collagen fibres in the
subcutaneous connective tissue after E3 administration.
Looseness or disorder of collagen fibres, which are con-
sidered to be one of the natural defence mechanisms against
tumour invasion (Van den Hooff, 1983), may conceivably
enhance infiltration of tumour cells into surrounding tissues.
Such changes in collagen fibres may simply be induced by a
rapid increase of intercellular matrix fluids including hyalur-
onic acid, whereas a direct influence of oestrogens on
collagen metabolism has been reported by Bentley et al.
(1986) and Hosokawa et al. (1981).
Histological observation on cellular components of the
tumour environment showed that E3 caused a marked
reduction in the number of eosinophils in subcutaneous
connective tissue compared -with controls treated with sol-
vent only. A decrease of eosinophils with antitumour activity
(Jong & Klebanoff, 1980; Iwasaki et al., 1986) may enhance
the growth of KE-5 cells. However, such a cellular response
may have resulted from the E3-induced suppression of
eosinophil infiltration, probably due to an ordinary inflam-
matory reaction after mechanical injury plus cellular effects
by normal thymocytes or KE-5 cells. Moreover, solvent itself
had little causative effect on eosinophil infiltration in the
skin. Macrophages and mast cells showed no change in
number, distribution or staining intensity due to E3. There-
fore, these cells seem unlikely to be major candidates for the
mediation of E3 tumour-promoting activity. In spite of the
marked increase in hyaluronic acid content, fibroblasts
showed little apparent morphological change due to E3 in
this study, as also reported by Branwood (1963).
Other immune mechanisms may also be involved in the
promotion of tumour growth. The involvement of tumour-
specific immune mechanisms mediated by immune lympho-
cytes may not be relevant to the present tumour model,
because the tumour-promoting effect of E3 was exhibited in
too short a time for this to have been the case. Furthermore,
NK cells may also not be involved in this tumour model,
because long-term exposure to oestrogens is required for the
reduction of NK activity (Seaman et al., 1978). At the early
stage of tumour growth, however, we cannot fully exclude
the possibility that E3 inhibits the production of some
antitumour factors in the tumour microenvironment, such as
interferons (Seaman et al., 1979; Gresser et al., 1979; Uno et
al., 1985), tumour necrosis factor (Carswell et al., 1975) or
tumour degenerating factor (Tanaka et al., 1985).
In conclusion, the present study suggests that increased
hyaluronic acid in the tumour environment may play a key
role in the tumour growth-promoting effect of E3. This
experimental model may help to explain the growth-
promoting effect of oestrogens on tumours lacking oestrogen
receptors as in the case of receptor-negative melanoma which
had its growth enhanced by oestrogens (Zava & Goldhirsch,
1983).
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